QuidelOrtho Appoints Erich Wolff as EVP of Strategy & Corporate Development

QuidelOrtho Appoints Erich Wolff as Executive Vice President of Strategy & Corporate Development, Strengthening Global Diagnostics Growth Ambitions QuidelOrtho Corporation, a leading global innovator in in vitro diagnostics, announced the appointment of Erich Wolff as its new Executive Vice President…

Read MoreQuidelOrtho Appoints Erich Wolff as EVP of Strategy & Corporate Development

Curant Rare Partners as Exclusive Pharmacy for FDA-Approved Neuroblastoma Drug IWILFIN™

Curant Rare Becomes Exclusive Pharmacy Partner for IWILFIN™, Transforming Access and Care for High-Risk Neuroblastoma Patients Curant Health has announced a major milestone in oncology care through its specialty division, Curant Rare, which is now the exclusive pharmacy partner for…

Read MoreCurant Rare Partners as Exclusive Pharmacy for FDA-Approved Neuroblastoma Drug IWILFIN™